Dolphin Medical Services Analysis

dividend

Pros

Cons

• Unable to evaluate Dolphin Medical Services's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Dolphin Medical Services's dividend against the top 25% market benchmark as the company has not reported any payouts.

health

Pros

• Dolphin Medical Services is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• The level of debt compared to net worth has been reduced over the past 5 years (61.9% vs 57.7% today).

Cons

• Debt is not well covered by operating cash flow (0.3%, less than 20% of total debt).
• Debt is not covered by short term assets, assets are 0.3x debt.
• Dolphin Medical Services's long term commitments exceed its cash and other short term assets.
• Dolphin Medical Services's level of debt (57.7%) compared to net worth is high (greater than 40%).
• High level of physical assets or inventory.

management

Pros

Cons

• The average tenure for the Dolphin Medical Services board of directors is less than 3 years, this suggests a new board.

misc

Pros

Cons

• Dolphin Medical Services is not covered by any analysts.
• Dolphin Medical Services has significant price volatility in the past 3 months.

past

Pros

Cons

• Unable to compare Dolphin Medical Services's 1-year earnings growth to the 5-year average as it is not currently profitable.
• Dolphin Medical Services does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
• It is difficult to establish if Dolphin Medical Services has efficiently used its assets last year compared to the IN Healthcare industry average (Return on Assets) as it is loss-making.
• It is difficult to establish if Dolphin Medical Services improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
• It is difficult to establish if Dolphin Medical Services has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
• Unable to compare Dolphin Medical Services's 1-year growth to the IN Healthcare industry average as it is not currently profitable.

value

Pros

• Dolphin Medical Services is good value based on assets compared to the IN Healthcare industry average.
• 526504 outperformed the Market in India which returned -14.5% over the past year.
• BSE:526504 is up 11.6% outperforming the Healthcare industry which returned 5.4% over the past month.
• BSE:526504 is up 11.6% outperforming the market in India which returned 8% over the past month.

Cons

• Dolphin Medical Services's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
• Dolphin Medical Services's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
• Dolphin Medical Services is loss making, we can't compare its value to the IN Healthcare industry average.
• Dolphin Medical Services is loss making, we can't compare the value of its earnings to the India market.
• 526504 underperformed the Healthcare industry which returned 9.1% over the past year.